BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1
682 results:

  • 1. Molecular classification and tumor microenvironment characteristics in pheochromocytomas.
    Qin S; Xu Y; Yu S; Han W; Fan S; Ai W; Zhang K; Wang Y; Zhou X; Shen Q; Gong K; Sun L; Zhang Z
    Elife; 2024 Feb; 12():. PubMed ID: 38407266
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.
    Else T; Jonasch E; Iliopoulos O; Beckermann KE; Narayan V; Maughan BL; Oudard S; Maranchie JK; Iversen AB; Goldberg CM; Fu W; Perini RF; Liu Y; Linehan WM; Srinivasan R
    Clin Cancer Res; 2024 May; 30(9):1750-1757. PubMed ID: 38393723
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epidemiology and economic burden of Von Hippel-Lindau Disease-associated central nervous system hemangioblastomas and pancreatic neuroendocrine tumors in the United States.
    Jonasch E; Song Y; Freimark J; Berman R; Nguyen H; Signorovitch J; Sundaram M
    Orphanet J Rare Dis; 2024 Feb; 19(1):73. PubMed ID: 38365728
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinico-pathologic profile and outcomes of pediatric endocrine patients managed by endocrine surgeons: Experience over three decades in a tertiary center in India.
    Vikram S; Mishra A; Bhatia V; Mayilvagnan S; Chand G; Agarwal G; Agarwal A; Dabadghao P; Mishra SK
    World J Surg; 2024 Mar; 48(3):729-738. PubMed ID: 38299448
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Ascites exosomal lncRNA PLADE enhances platinum sensitivity by inducing R-loops in ovarian cancer.
    Liu H; Deng S; Yao X; Liu Y; Qian L; Wang Y; Zhang T; Shan G; Chen L; Zhou Y
    Oncogene; 2024 Mar; 43(10):714-728. PubMed ID: 38225339
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. EPAS1-mutated paragangliomas associated with haemoglobin disorders.
    Mancini M; Buffet A; Porte B; Amar L; Lussey-Lepoutre C; Crinière L; Baudin E; Meatchi T; Gimenez-Roqueplo AP; Favier J; Burnichon N
    Br J Haematol; 2024 Mar; 204(3):1054-1060. PubMed ID: 38195958
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Multiple neuroendocrine tumors of the pancreas].
    Sipos B
    Pathologie (Heidelb); 2024 Feb; 45(1):28-34. PubMed ID: 38180510
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genotype-phenotype correlations in paediatric and adolescent phaeochromocytoma and paraganglioma: a cross-sectional study.
    Seabrook A; Vasudevan A; Neville K; Gerstl B; Benn D; Smith J; Kirk J; Gill A; Clifton-Bligh R; Tucker K
    Arch Dis Child; 2024 Feb; 109(3):201-208. PubMed ID: 38071512
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.
    Wang Y; Liu B; Li F; Zhang Y; Gao X; Wang Y; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1274239. PubMed ID: 37867526
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. EUS-guided fine needle aspiration-based clues to mistaken or uncertain identity: serous pancreatic cysts.
    Yip-Schneider MT; Muraru R; Kim RC; Wu HH; Sherman S; Gutta A; Al-Haddad MA; Dewitt JM; Schmidt CM
    HPB (Oxford); 2023 Dec; 25(12):1587-1594. PubMed ID: 37749004
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Promising targetable biomarkers in pancreatic neuroendocrine tumours.
    Borghesani M; Gervaso L; Cella CA; Benini L; Ciardiello D; Algeri L; Ferrero A; Valenza C; Guidi L; Zampino MG; Spada F; Fazio N
    Expert Rev Endocrinol Metab; 2023; 18(5):387-398. PubMed ID: 37743651
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pheochromocytoma and paraganglioma in children and adolescents.
    Stachowicz-Stencel T; Pasikowska N; Synakiewicz A
    Acta Biochim Pol; 2023 Sep; 70(3):487-493. PubMed ID: 37717273
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hypoxia-associated genetic signature in ovarian steroid cell tumor NOS.
    Chao A; Huang HJ; Lin CY; Lee CH; Lin CH; Chao AS; Lai CH; Chang TC; Wu KY; Wu RC
    Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37655726
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical Characteristics and Long-Term Outcomes of Adrenal Tumors in Children and Adolescents.
    Kim JH; Choi Y; Hwang S; Yoon JH; Kim GH; Yoo HW; Choi JH
    Exp Clin Endocrinol Diabetes; 2023 Oct; 131(10):515-522. PubMed ID: 37437600
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Discovery of potent NAMPT-Targeting PROTACs using FK866 as the warhead.
    Zhang P; Wang W; Guo M; Zhou L; Dong G; Xu D; Sheng C
    Bioorg Med Chem Lett; 2023 Aug; 92():129393. PubMed ID: 37369332
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis.
    Pflüger MJ; Jamouss KT; Afghani E; Lim SJ; Rodriguez Franco S; Mayo H; Spann M; Wang H; Singhi A; Lennon AM; Wood LD
    Pancreatology; 2023 Nov; 23(7):868-877. PubMed ID: 37230894
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Domain landscapes of somatic NF1 mutations in pheochromocytoma and paraganglioma.
    Tabebi M; Frikha F; Volpe M; Gimm O; Söderkvist P
    Gene; 2023 Jul; 872():147432. PubMed ID: 37062455
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Personalized Systemic Therapies in Hereditary cancer Syndromes.
    Mastrodomenico L; Piombino C; Riccò B; Barbieri E; Venturelli M; Piacentini F; Dominici M; Cortesi L; Toss A
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980956
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
    Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
    Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Discovery of Highly Potent Nicotinamide Phosphoribosyltransferase Degraders for Efficient Treatment of Ovarian cancer.
    Bi K; Cheng J; He S; Fang Y; Huang M; Sheng C; Dong G
    J Med Chem; 2023 Jan; 66(1):1048-1062. PubMed ID: 36563407
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 35.